Determination of 6-Nitro-7-(4'-Nitrophenyl)-5-Ethyl-4,7-Dihydropyrazolo[1,5-a]Pyrimidine-3-Carboxylate as a Potential Antitumor Agent by Voltammetry

P. N. Mozharovskaia; Можаровская П. Н.; A. V. Ivoilova; Ивойлова А. В.; A. A. Terekhova; Терехова А. А.; A. N. Tsmokalyuk; Цмокалюк А. Н.; A. V. Ivanova; Иванова А. В.; A. N. Kozitsina; Козицина А. Н.; V. L. Rusinov; Русинов В. Л.

doi:10.31857/S0044450223020081

Determination of 6-Nitro-7-(4'-Nitrophenyl)-5-Ethyl-4,7-Dihydropyrazolo[1,5-a]Pyrimidine-3-Carboxylate as a Potential Antitumor Agent by Voltammetry

Authors: Mozharovskaia P.N.¹, Ivoilova A.V.¹, Terekhova A.A.¹, Tsmokalyuk A.N.¹, Ivanova A.V.¹, Kozitsina A.N.¹, Rusinov V.L.¹^,2
Affiliations:
1. Ural Federal University named after the first President of Russia B.N. Yeltsin
2. Postovskii Institute of Organic Synthesis, Ural Branch, Russian Academy of Sciences
Issue: Vol 78, No 3 (2023)
Pages: 260-267
Section: ORIGINAL ARTICLES
Submitted: 31.01.2025
URL: https://ruspoj.com/0044-4502/article/view/650166
DOI: https://doi.org/10.31857/S0044450223020081
EDN: https://elibrary.ru/FUUGSE
ID: 650166

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription or Fee Access

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

6-Nitro-7-(4'-nitrophenyl)-5-ethyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylate (1) is one of promising antitumor compounds exhibiting biological activity against type 2 casein kinase, which is currently considered as a promising target in chemotherapy. Using the method of cyclic voltammetry, it was shown that the electrochemical activity of compound 1 in a mixed solution of Tris-HCl and ethanol (1 : 1) at pH 7.5 on a glassy-carbon electrode is due to the electrochemical reduction of the nitro group conjugated with the phenyl ring. A method was developed for the determination of compound 1 by direct cathodic square-wave voltammetry. The linearity region of the corresponding calibration curve obtained in a solution of a mixture of Tris-HCl and ethanol (1 : 1) at pH 7.5 is 5–500 mg/L (R2 = 0.988), the limit of detection is 0.8 mg/L, the limit of quantification is 2.4 mg/L. The accuracy of the developed procedure is close to 100%, the relative standard deviation is 1.4%.

Keywords

quantitative substance analysis, square-wave voltammetry, pyrazolopyrimidines, nitro group, glassy-carbon electrode, antitumor agent,

References

Pilleron S., Sarfati D., Janssen-Heijnen M., Vignat J., Ferlay J., Bray F., Soerjomataram I. Global cancer incidence in older adults, 2012 and 2035: A population-based study // Int. J. Cancer. 2019. V. 144. № 1. P. 49.
Davatgaran-Taghipour Y., Masoomzadeh S., Farzaei M.H., Bahramsoltani R., Karimi-Soureh Z., Rahimi R., Abdollahi M. Polyphenol nanoformulations for cancer therapy: Experimental evidence and clinical perspective // Int. J. Nanomed. 2017. V. 12. P. 2689.
Abdelaziz H.M., Gaber M., Abd-Elwakil M.M., Mabrouk M.T., Elgohary M.M., Kamel N.M., Kabary D.M., Freag M.S., Samaha M.W., Mortada S.M. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates // J. Control. Release. 2018. V. 269. P. 374.
Madamsetty V.S., Mukherjee A., Mukherjee S. Recent trends of the bio-inspired nanoparticles in cancer theranostics // Front. Pharmacol. 2019. V. 10. P. 1264.
Fuchi Y. Murase H., Kai R., Kurata K., Karasawa S., Sasaki S. Artificial host molecules to covalently capture 8-Nitro-cGMP in neutral aqueous solutions and in cells // Bioconjug. Chem. 2021. V. 32. № 2. P. 385.
Denny W.A., Wilson W.R., Stevenson R.J., Tercel M., Atwell G.J., Yang S. Patterson V.A. Nitrobenzindoles and their use in cancer therapy. U.S. Patent No. 7718688. 18.05.2010.
Wardman P. Application of pulse radiolysis methods to study the reactions and structure of biomolecules // Rep. Prog. Phys. 1978. V. 21. № 2. P. 259.
Grunberg E., Titsworth E.H. Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings // Ann. Rev. Microbiol. 1973. V. 27. № 21. P. 317.
Alavi M., Nokhodchi A. Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: Recent advances and challenges // Drug Discov. Today. 2022. V. 27. № 2. P. 576.
Bhatnagar I., Kim S-K. Marine antitumor drugs: Status, shortfalls and strategies // Marine Drugs. 2010. V. 8. № 10. P. 2702.
Pérez-Herrero E., Fernández-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy // Eur. J. Pharm. Biopharm. 2015. V. 93. P. 52.
Asati V., Anant A., Patel P., Kaur K., Gupta G.D. Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches // Eur. J. Med. Chem. 2021. V. 225. Article 113781.
Pagano M.A., Cesaro L., Meggio F., Pinna L.A. Protein kinase CK2: A newcomer in the “druggable kinome” // Biochem. Soc. Trans. 2006. V. 34. № 6. P. 1303.
Squella J.A., Bollo S., Núñez-Vergara L.J. Recent developments in the electrochemistry of some nitro compounds of biological significance // Curr. Org. Chem. 2005. V. 9. № 6. P. 565
Малахова Н.А., Ивойлова А.В. Замана А.А., Русинов В.Л., Алямовская И.С., Иванова А.В., Козицина А.Н. Количественное определение основного вещества противовирусного препарата Триазид® с использованием метода вольтамперометрии // Журн. аналит. химии. 2020. Т. 75. № 3. С. 266.
Bonfilio R., De Araújo B.M., Salgado H.R.N. Recent applications of analytical techniques for quantitative pharmaceutical analysis: A review // WSEAS Trans. Biol. Biomed. 2010. T. 7. № 4. P. 316.
El-Shahawi M.S., Bahaffi S.O., El-Mogy T. Analysis of domperidone in pharmaceutical formulations and wastewater by differential pulse voltammetry at a glassy-carbon electrode // Anal. Bioanal. Chem. 2007. V. 387. № 2. P. 719.
Zittel H.E., Miller F.J. A glassy-carbon electrode for voltammetry // Anal. Chem. 1965. V. 37. № 2. P. 200.
Baizer M. M., Lund H. Organic Electrochemistry. New York, 1983. P. 1166.